Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-07
1998-08-18
Degen, Nancy
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
424 9464, 435 691, 435 692, 435 696, 514 2, 514 8, 530384, 530395, A61K 3836, A61K 3848, A61K 3514, C07K 14745
Patent
active
057958637
ABSTRACT:
Analogs of Factor Xa (Factor Xai) which are inactive as proteases in the prothrombinase reaction are useful in treatment of diseases characterized by thrombosis. These antithrombotic agents can be conveniently prepared using recombinant techniques.
REFERENCES:
patent: 4337244 (1982-06-01), Smith
patent: 4382083 (1983-05-01), Thomas
patent: 4604285 (1986-08-01), Smith et al.
patent: 4970300 (1990-11-01), Fulton et al.
patent: 5120537 (1992-06-01), Esmon et al.
patent: 5278144 (1994-01-01), Wolf
patent: 5597799 (1997-01-01), Wolf
Neuenschwander et al. "The use of Acylated Factor X to Prevent Feedback Activation of Factor VIII During Factor X Activation . . . "Anal Biochem. 184 347-352 1990.
Fung et al. "Characterization of an Almost Full-Length cDNA Coding for Human Blood Coagulation Factor X" PNAS 82 3591-3595 1985.
Bajaj et al., J. Biol. Chem., vol. 248(22), pp. 7729-7741 (1973).
Bernardi, F. et al., Blood, vol. 73, pp. 2123-2127 (1989).
Cassels, R. et al., Biochem. J., vol. 247, pp. 359-400 (1987).
Colman et al., Haemostasis and Thrombosis, Second Edition, R.W. Colman et al., eds., (1987) J.B. Lippencott, Philadelphia, PA, Section 1, Chapter 1, pp. 3-17.
Crabbe, S.J. et al., Pharmacotherapy, vol. 10, pp. 115-126 (1990).
Davie, E.W., Hemostasis and Thrombosis, Second Edition, R.W. Coleman et al. eds. (1987), p. 250.
DiScipio, R.G., et al., Biochemistry, vol. 16, p. 5253 (1977).
Donwiddie, C. et al., J. Biol. Chem., vol. 264, p. 16694 (1989).
Ehrlich et al., Journal of Biological Chemistry, vol. 264, pp. 14298-14304 (1989).
Etingin, O.R., et al., Cell, vol. 61, p. 657 (1990).
Fair, D.S. et al., Blood, vol. 73, pp. 2108-2116 (1989).
Fears, R. et al., Seminars in Thrombosis and Homeostasis, vol. 15, pp. 129-139 (1989).
Fears, R. et al., Drugs, vol. 33: Supp. 3, pp. 57-63 (1987).
Fung et al., Proc. Natl. Acad. Sci. USA, vol. 82, pp. 3591-3595 (1985).
Furie, B. et al., Cell, vol. 53, p. 505 (1988).
Girard, T.J. et al., Nature, vol. 338, p. 518 (1989).
Girard, T.J. et al., Science, vol. 248, p. 1421 (1990).
Grabbe et al., Pharmaco-Therapy, vol. 10, pp. 115-126 (1990).
Hanson, R.S. et al., Proc. Natl. Acad. Sci. USA, vol. 85, p. 3184 (1988).
Hase et al., J. Biol. Chem., vol. 265, pp. 1858-1861 (1990).
Hassan, H.J. et al., Blood, vol. 71, pp. 1353-1356 (1988).
Hoover, R.J. et al., Cell, vol. 14, p. 423 (1978).
Husten, E.J., et al., J. Biol. Chem., vol. 262, pp. 12953-12961 (1987).
Kaul et al., Gene, vol. 41, pp. 311-314.
Krishnaswamy, S. et al., J. Biol. Chem., vol. 263, pp. 3823-3824 (1988).
Levine, Plasma "Clinical Manifestations and Therapy of Hemophilias A and B", Coagulation Factors, pp. 97-111.
Lusher, J.M., "Management of Hemophiliacs with Inhibitors, Hemophilia in the Child and Adult," M. Hilgartner and C. Pochedly, eds. New York, Raven Press, 1989.
Mizouchi et al., J. Biol. Chem., vol. 255, pp. 3526-3531 (1980).
Nesheim, H.E. et al., J. Biol. Chem., vol. 254, p. 10952 (1979).
Nesheim, M.E. et al., J. Biol. Chem., vol. 256, pp. 6537-6540 (1981).
Neuenschwander et al., Anal. Biochem., vol. 184, pp. 347-352 (1990).
Nucci et al., Adv. Drug. Delivery Rev., vol. 6, pp. 133-151 (1991).
Reddy, S.B., et al., Blood, vol. 74, pp. 1486-1490 (1989).
Skogen, W.F. et al., J. Biol. Chem., vol. 256, pp. 2306-2310 (1984).
Smith et al., "Structure-activity Relationships for the Formation and Breakdown of Acylated Fibrinolytic Enzymes," in Progress in Fibrolysis, Davidson, J.F. et al., eds., London England: Churchill Livingstone, 1985, pp. 227-231.
Steinberg, M. et al., Hemostasis and Thrombosis, Coleman, R.W. et al. eds. (1987) J.B. Lippencott, Phila., PA, Chapter 7, pp. 112.-119.
Sturzebecher, J. et al., Thrombosis Res., vol. 47, pp. 699-703 (1987).
Titani, Proc. Natl. Acad. Sci., vol. 72, pp. 3082-3086 (1975).
Watzke, H.H. et al., J. Biol. Chem., vol. 285, pp. 11982-11989 (1990).
Waxman, L. et al., Science, vol. 248, p. 593 (1990).
COR Therapeutics Inc.
Degen Nancy
LandOfFree
Recombinant agents affecting thrombosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant agents affecting thrombosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant agents affecting thrombosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1114763